INT258317

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.41
First Reported 2008
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.77
Pain Relevance 0.11

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleolus (Ms4a1)
Ms4a1 (Mus musculus)
Pain Link Frequency Relevance Heat
rheumatoid arthritis 109 77.52 Quite High
Inflammation 9 5.00 Very Low Very Low Very Low
methotrexate 4 5.00 Very Low Very Low Very Low
dexamethasone 3 5.00 Very Low Very Low Very Low
vincristine 3 5.00 Very Low Very Low Very Low
chemokine 3 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
Central nervous system 1 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
cINOD 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Chronic Lymphoid Leukemia 14 99.44 Very High Very High Very High
Lymphatic System Cancer 82 97.72 Very High Very High Very High
Multiple Myeloma 8 82.36 Quite High
Acquired Immune Deficiency Syndrome Or Hiv Infection 4 77.96 Quite High
Htlv Types I And Ii 5 77.76 Quite High
Disease 48 77.56 Quite High
Rheumatoid Arthritis 109 77.52 Quite High
Severe Combined Immunodeficiency 16 75.04 Quite High
Mantle-cell Lymphoma 13 68.00 Quite High
Follicular Lymphoma 13 66.96 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Alemtuzumab, an anti-CD52 antibody, has been approved for the treatment of CLL, and radioimmunoconjugates targeting CD20 are in use for patients with follicular and transformed lymphoma and also for other lymphoma subtypes.
Localization (targeting) of CD20 associated with chronic lymphoid leukemia and lymphatic system cancer
1) Confidence 0.41 Published 2008 Journal Biologics : Targets & Therapy Section Body Doc Link PMC2727901 Disease Relevance 1.48 Pain Relevance 0
ACPA+ cells were localised around AID+/CD21+ aggregates (Figure 4D, 4E and 4F), were CD20?
Localization (localised) of CD20
2) Confidence 0.15 Published 2009 Journal PLoS Medicine Section Body Doc Link PMC2621263 Disease Relevance 0.29 Pain Relevance 0.11

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox